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A novel technique for preoperative MRI guided wire localization for targeted surgical excisional biopsy of muscle is
described in a pediatric patient with juvenile dermatomyositis (JDM). This technique allows for preoperative
localization of abnormalities seen only with MRI. Using this technique, the patient underwent successful targeted
muscle biopsy for confirmation of the diagnosis and staging of dermatomyositis.
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Juvenile dermatomyositis (JDM) is an autoimmune, in-
flammatory myopathy. Dermatologic and muscle mani-
festations are most common, typically consisting of a
heliotrope rash involving the eyelids, erythematous rash
on the extensor surfaces (Gottron’s papules), and prox-
imal muscle weakness [1,2]. Surgical muscle biopsy is
diagnostic for cases in which the clinical presentation
may not be clear. However, the muscle biopsy can be dif-
ficult because even within a single muscle group there
can be heterogeneous inflammatory involvement. This
patchy muscular involvement can only be delineated with
magnetic resonance imaging (MRI) [3]. This complicates
the surgical biopsy because grossly the muscular tissue all
looks the same. Due to this, the surgeon must either take
more tissue than is absolutely necessary or repeat biopsies
may be required.
This case report presents a novel methodology for pre-
operative muscle localization in a patient needing surgical
excisional biopsy for diagnosis of JDM. This technique
utilizes MRI guidance for the advantage of soft tissue
resolution and accurate targeting of the patchy muscular
inflammation for surgical biopsy.* Correspondence: Woodrum.david@mayo.edu
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A 5-year old boy presented to his family physician with
a one week history of a raised, erythematous rash over
the nasal bridge and ears. The patient had no additional
symptoms. Initial diagnosis of atopic dermatitis versus
allergy was made and treatment with mild topical steroid
creams and antihistamines was initiated. Over the course
of one month the rash worsened, spreading to involve
the nose, bilateral cheeks and ears, and upper back. The
patient’s mother noted worsening of the rash with sun
exposure. Again, no other symptoms were noted at this
time. Given the progressive nature of rash and failure to
improve on topical steroids, the patient was referred to
dermatology by his family physician.
Dermatologic evaluation described an erythematous,
confluent papular rash on the bridge of the nose and
extending over both cheeks, sparing the naso-labial
folds. Several excoriations were noted in association with
the rash. Similar rashes were present behind the ears
and on the back, chest, and extensor surfaces of the
upper and lower extremities bilaterally. Due to the char-
acteristic malar rash and clinical presentation, differential
diagnosis including JDM, cutaneous lupus, and atopic
dermatitis were considered. A punch biopsy of the right
posterior auricular region was performed which showed
changes compatible with connective tissue disease such as
lupus erythematosus or JDM including parakeratosis, epi-
dermal atrophy, basal vacuolization, cytoid bodies along
the dermal-epidermal junction, dermal telangiectasias and
a moderate perivascular and perifollicular lymphocyticd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
Figure 1 MRI of the gluteus maximus muscles demonstrating enhancement consistent with myopathy. (A) T1, (B) T2 fast spin echo (FSE),
and (C) fat saturated T1 post gadolinium images demonstrate normal T1 signal and confluent increased T2 signal with associated gadolinium
enhancement in the gluteus maximus muscles.
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clobetasol topical steroid cream which resulted in mild
improvement in the skin lesions.
Approximately one month later, the patient began to
experience left knee pain without inciting injury. With the
suspicion for lupus or JDM and new joint pain, the pa-
tient was referred to a pediatric rheumatologist. Physical
exam demonstrated rash as noted previously, no arthritis
of the knee though range of motion was tight, and no
muscle weakness was found using manual muscle testing
and Childhood Myositis Assessment Scale (CMAS). Sero-
logic testing, including anti-nuclear antibody testing, in-
flammatory markers, and serum levels of muscle-derived
enzymes were within normal limits. Given the negative
ANA and physical exam findings; notably the distribution
of the skin rash the presentation was thought to be more
consistent with JDM than lupus erythematosus. An MRI
was performed to evaluate for evidence of myositis. MRI
showed patchy increased T2 signal with associated gado-
linium contrast enhancement within the anterior, pos-
terior, and medial compartment musculature of the thighs
and within the gluteus maximus bilaterally, consistent
with myopathy (Figures 1 and 2).
The combination of clinical, laboratory, and imaging
findings were thought to be consistent with the diagnosis
of JDM. The patient, however, did not satisfy complete
diagnostic criteria for JDM; therefore muscle biopsy was
recommended for confirmation and staging of the condi-
tion including inflammatory infiltrate amount and other
changes to help aid in prognosis. Surgery was consultedFigure 2 MRI of the thigh musculature demonstrating enhancement c
post gadolinium images demonstrate normal T1 signal and patchy increase
vastus intermedius, vastus lateralis muscles.for the muscle biopsy. Though the gluteus maximus
appeared most diffusely involved on the MRI, the vastus
lateralis is a more commonly and safely biopsied area. Due
to the relative patchy involvement of the vastus lateralis,
preoperative imaging localization was explored. Ultra-
sound of the gluteal and thigh muscles was performed,
however the muscles demonstrated normal echotexture
with no distinct abnormality to which the surgeons could
be directed for biopsy. MRI guidance with wire local-
ization for biopsy was requested.
The patient was brought to the MR (GE Signa 1.5 T, GE
Medical, Milwaukee, WI) suite anteroom where anesthesia
was initiated. The patient was transferred to the MR
table in a supine feet-first position. Initial skin fiducials
were placed on the lateral thighs bilaterally for reference
markers (Figure 3). Coronal T2 images with fat saturation
(TR 3000, TE 65, NEX 1, Flip angle 90, FOV 300, slice
thickness 5 mm, echo train 8, matrix 256x224) were
acquired to identify the position of the fiducials to the
patchy muscular involvement in the vastus lateralis. Next
axial T2 images with fat saturation (TR 4250, TE 66, NEX
2, Flip angle 90, FOV 280, slice thickness 5 mm, echo train
8, matrix 256×192) were acquired confirming entry pos-
ition targeting the patchy involvement in both the right
and left vastus lateralis. Using intermittent axial T2 im-
ages, 18-gauge MRI compatible wire localization needles
were placed into the inferior aspects of each vastus
lateralis at locations of increased T2 signal. Needle pos-
ition within the high T2 signal in the vastus lateralis was
confirmed with axial T2 images (Figure 4). The localizingonsistent with myopathy. (A) T1, (B) T2 FSE, and (C) fat saturated T1
d T2 signal with corresponding gadolinium enhancement in the
Figure 3 MRI of skin fiducials on lateral thighs. (A) Coronal and (B) axial T2 images show skin markers (arrows) overlying the high T2 signal
within the vastus lateralis muscles bilaterally.
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to the skin for surgical biopsy. Localization and placement
of the localizing wires took approximately one hour.
The patient then proceeded to the operating room,
where the localization wires led the surgeon directly to
affected muscle tissue for biopsy. Evaluation of the bi-
opsy specimen demonstrated perifascicular abnormal-
ities and perivascular inflammation. Given the results of
the skin and muscle biopsies, in addition to the clinical
picture, the diagnosis was determined to be consistent
with moderately severe active dermatomyositis. After
pathologic confirmation of the JDM diagnosis, the pa-
tient was started on treatment with oral prednisone and
methotrexate.
Conclusions
Juvenile dermatomyositis is an autoimmune, inflamma-
tory myopathy. Though a rare disease, it is the most
common inflammatory myopathy in children with an in-
cidence of 2–3 cases per million children per year [1,4].
Skin rashes and proximal muscle weakness are the most
common symptoms, typically consisting of a heliotrope
rash involving the eyelids, erythematous rash on the ex-
tensor surfaces (Gottron’s papules), and proximal muscle
weakness [1,2]. Gastrointestinal, pulmonary, cardiac, and
joint involvement, as well as other organ system involve-
ment can also be seen, but is less common [5].Figure 4 MRI of the needle position within the high T2 signal in the v
wire-localization show the localization wires (arrows) are located within regThe diagnosis of JDM has historically been established
using a combination of clinical, microscopic, laborato-
ry, and electromyographic abnormalities. In 1975, Bohan
and Peter published criteria for diagnosis of JDM [6].
Throughout the years, many additional authors have sug-
gested adding to or modification of the Bohan and Peter
criteria for diagnosis of JDM. For example, Tanimoto
et al. [7] suggested the addition of more clinical findings
to the diagnostic criteria, while Love et al. [8] suggested
diagnostic classification based upon presence of specific
autoantibodies.
Imaging findings are not included in the criteria for
diagnosis of JDM; however, many clinicians have been
using imaging as a tool for diagnosis and monitoring of
disease activity [2]. Ultrasound may demonstrate edema
and swollen muscle fibers in the affected muscles [9].
MRI findings of symmetric muscular edema are typical of
JDM, however the intramuscular edema may be patchy
[2,10,11]. Fatty infiltration and muscle atrophy may be
evident on T1 MRI images in chronically affected mus-
cles [2,3,10].
Prior to the availability of immunosuppressive medi-
cations, the prognosis of patients with JDM was poor.
While approximately one-third of these patients re-
covered without sequelae of their disease, another one-
third of these patients died from their disease, and the
remaining one-third survived but had serious permanentastus lateralis. (A) Axial and (B) coronal T2 images performed post
ions of high T2 signal in the vastus lateralis muscles bilaterally.
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tions significantly decreased the mortality rate. Current
treatment of JDM typically consists of oral or IV cortico-
steroids, often in combination with other immunosup-
pressive drugs, most commonly methotrexate. With the
currently available treatments, the mortality rate is now
estimated to be one to two percent [13]. Given the dra-
matically decreased mortality rates in patients treated
with immunosuppressive therapy, prompt diagnosis and
treatment of JDM is imperative.
For cases in which the diagnosis of JDM is unclear
or the clinician seeks to stage the severity of the condi-
tion in efforts to predict clinical course and guide ther-
apy regimens, the radiologist may be asked to assist by
evaluating for imaging evidence of myopathy or to per-
form biopsy or localization for surgical excisional biopsy.
Studies by Crowe et al. [14], Wargula et al. [15], and
Miles et al. [16] have supported the predictive value of
muscle biopsy in the treatment and prognosis of JDM.
Preoperative hookwire localization has long been
performed in breast imaging, typically using mammo-
graphic and/or ultrasound guidance. More recently, with
the advent of MRI compatible equipment, hookwire
and needle localization has also been performed in breast
imaging using MR guidance [17]. A multi-center trial ex-
amined MRI guided wire localization of clinically and
mammographically occult lesions of the breast and found
it to be beneficial, especially in lesions that were diffi-
cult to see mammographically [18]. Preoperative wire
localization has expanded to be used to localize lesions in
multiple locations throughout the body, including intra-
muscular lesions [19].
Our case illustrates that MRI guided wire localization
is a feasible technique for targeting affected muscle for
surgical excisional biopsy in cases where there is patchy
distribution of pathology seen only with MRI. Future in-
vestigations will seek to evaluate this methodology in
assisting the work up of patients with difficult or confus-
ing clinical presentations of JDM.Consent
The institutional review board (IRB) at our institution
was contacted regarding this case; however it was deter-
mined that IRB approval, consenting, and/or a protocol
were not required for this single retrospective case re-
port. All data was handled confidentially with no identi-
fying information.
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